Video Player
  • Email
  • share

AbbVie clinches Shire deal

AbbVie succeeds in its pursuit of Shire with a $53 billion deal which will give the U.S. pharma giant access to Shire's premium medicines for rare diseases, and, potentially, slash its tax bills. David Pollard reports.

http://www.kare11.com/video/3682520260001/1/AbbVie-clinches-Shire-deal http://cdn.newslook.com/a1/a1bdd6bf1492c69cda3a7e0b8cbc989d/images/frame_ext.jpg AbbVie clinches Shire deal AbbVie succeeds in its pursuit of Shire with a $53 billion deal which will give the U.S. pharma giant access to Shire's premium medicines for rare diseases, and, potentially, slash its tax bills. David Pollard reports. americaFinanceMike IngramdublinBGC PartnersInc.usUnited KingdomBGCPdavid pollardnewslookUnited States of Americachicago 01:45

Next Up

    

More Videos